[logo] HealthTree Foundation
more_vert

MDS and Cancer: Clearing the Confusion with Dr. Marando

MDS and Cancer: Clearing the Confusion with Dr. Marando image

MDS and Cancer: Clearing the Confusion with Dr. Marando

Podcast
event Feb 09, 2026 11:00AM - Feb 10, 2026 11:01AM EST
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

In this episode, Dr. Ludovica Marando discusses the complexities of Myelodysplastic Syndromes (MDS) and clonal hematopoiesis (CH). She explains the challenges in treating MDS, the significance of understanding CH, and the confusion surrounding MDS as a form of cancer. The discussion also covers the importance of risk stratification in MDS treatment and the current research aimed at preventing the progression of these conditions.

Schedule & Agenda

The panelist Mary Arnett
11:00 AM
Introduction
Mary Arnett

Mary introduces the agenda of the event and our featured speaker Dr. Ludovica Marando

Event panelist Ludovica Marando, MD
11:05 AM
Discussion
Ludovica Marando, MD

Dr. Ludovica Marando discusses the complexities of Myelodysplastic Syndromes (MDS) and clonal hematopoiesis (CH) and answers your questions

Speakers & Moderators

The panelist Mary Arnett
Mary Arnett
Salt Lake City, UT

Mary joined HealthTree in 2022. She is now the AML & MDS Patient Engagement Manager. She is passionate about giving power to patients through knowledge and health education. If she can help one patient feel more confident participating in discussions with their healthcare team and making treatment decisions, she will feel like she has succeeded. When she isn't advocating for patients, she loves being an aunt, attending concerts, and experimenting with new recipes in the kitchen.

Read Bio
person
Ludovica Marando, MD

Dr. Ludovica Marando is a blood cancer specialist and researcher at Baylor College of Medicine in Houston. She cares for patients with conditions that can lead to leukemia and studies why some people are at higher risk of developing these diseases. Her research focuses on understanding early warning signs in the blood—changes known as “clonal hematopoiesis”—that can sometimes turn into leukemia. By studying these changes in detail, Dr. Marando hopes to develop more effective methods for identifying individuals at risk and preventing blood cancers before they develop.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Myelodysplastic Syndromes Discussion group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

newsletter icon

Get the Latest Myelodysplastic Syndromes Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.

Together we care.

Together we cure.

100% of every dollar you give supports our life-changing mission.